Market Tracker

07/25 6:05pm ET

Myriad Genetics Inc (NASDAQ:MYGN)

During the Trading Day
37.02 -0.33 / -0.88%
Data as of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
37.07 +0.05 / +0.14%
 
Volume: 300.00

Today’s Trading

Previous close37.35
Today’s open37.26
Day’s range36.80 - 37.70
Volume509,399
Average volume (3 months)1,102,903
Market cap$2.8B
Dividend yield--
Data as of 4:00pm ET, 07/25/2014

Growth & Valuation

Earnings growth (last year)+36.15%
Earnings growth (this year)+35.83%
Earnings growth (next 5 years)+14.93%
Revenue growth (last year)+23.62%
P/E ratio15.8
Price/Sales3.55
Price/Book4.13

Competitors

 Today’s
change
Today’s
% change
THRXTheravance Inc-0.94-3.94%
NPSPNPS Pharmaceuticals ...-0.07-0.24%
WXWuXi Pharmatech (Cay...-0.04-0.12%
IRWDIronwood Pharmaceuti...-0.04-0.26%
Data as of 4:04pm ET, 07/25/2014

Financials

Next reporting dateAugust 12, 2014
EPS forecast (this quarter)$0.46
Annual revenue (last year)$613.2M
Annual profit (last year)$147.1M
Net profit margin24.00%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Peter D. Meldrum
Executive Vice President-
International Operations
Gary A. King
Corporate headquarters
Salt Lake City, Utah

Forecasts